Sign in

CIK 0001630627

  • Accelerated filer

TREACE MEDICAL CONCEPTS, INC.

Sign in to watch
Ticker
TMCI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
FL
Entity type
Operating
EIN
471052611
Phone
+1 904-373-5940
Business address
100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
Open-market buys, last 90 days
$47,731
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$47,731. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Treace John T. +$48K Chief Executive Officer 1 filing

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-09-12 Scanlan Sean F. Chief Innovation Officer Exercise or conversion +33,750 $0.10 $3K 250,074
2024-09-12 Scanlan Sean F. Chief Innovation Officer Exercise or conversion · Stock Option (Right to Buy) −33,750 0
2024-08-09 Scanlan Sean F. Chief Innovation Officer Grant or award +120,900 216,324
2024-03-10 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −1,396 95,424
2024-03-08 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −389 96,820
2024-01-10 Scanlan Sean F. Chief Innovation Officer Grant or award +65,025 97,209
2024-01-10 Scanlan Sean F. Chief Innovation Officer Grant or award · Stock Option (Right to Buy) +73,200 73,200
2023-11-02 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −211 32,184
2023-05-16 Scanlan Sean F. Chief Innovation Officer Exercise or conversion +25,000 $0.10 $3K 57,395
2023-05-16 Scanlan Sean F. Chief Innovation Officer Sale −25,000 $25.44 $636K 32,395
2023-05-16 Scanlan Sean F. Chief Innovation Officer Exercise or conversion · Stock Option (Right to Buy) −25,000 33,750
2023-03-10 Scanlan Sean F. Chief Innovation Officer Grant or award +22,925 32,395
2023-03-10 Scanlan Sean F. Chief Innovation Officer Grant or award · Stock Option (Right to Buy) −51,950 51,950
2023-03-09 Scanlan Sean F. Chief Innovation Officer Sale −505 $24.41 $12K 9,470
2023-02-15 Scanlan Sean F. Chief Innovation Officer Exercise or conversion +25,000 $0.10 $3K 34,975
2023-02-15 Scanlan Sean F. Chief Innovation Officer Sale −25,000 $21.69 $542K 9,975
2023-02-15 Scanlan Sean F. Chief Innovation Officer Exercise or conversion · Stock Option (Right to Buy) −25,000 $0.10 $3K 58,750
2023-01-12 Scanlan Sean F. Chief Innovation Officer Exercise or conversion +25,000 $0.10 $3K 34,975
2023-01-12 Scanlan Sean F. Chief Innovation Officer Sale −25,000 $25.57 $639K 9,975
2023-01-12 Scanlan Sean F. Chief Innovation Officer Exercise or conversion · Stock Option (Right to Buy) −25,000 $0.10 $3K 83,750

Page 2 of 3 · 45 trades